From: Prevalence of antiplatelet therapy in patients with diabetes
Characteristic | N | Mean or Prevalence |
---|---|---|
Female | 435 | 55% |
Age, mean (SD) (range) | 785 | 64 (11.8) (31–93) |
Age > = 65 | 395 | 50% |
Race/Ethnicity | ||
White, non-Hispanic | 764 | 97.6% |
Education | ||
High school graduate | 599 | 77% |
Marital Status | ||
Married or living as married | 503 | 64% |
Current smoker | 125 | 16% |
Endocrinology consult visit in past year | 122 | 16% |
Diabetes education visit in past year | 173 | 23% |
Insurance Status * | ||
None | 21 | 2.7% |
Private | 472 | 60.5% |
Medicare | 447 | 57.6% |
Medicaid | 143 | 18.5% |
Military | 33 | 4.3% |
Annual household income | ||
< $30,000 | 407 | 56.4% |
Body Mass Index | ||
Normal (< 25) | 85 | 10.9% |
Overweight (25–29.9) | 182 | 23.4% |
Obese (> = 30) | 510 | 65.6% |
Very Obese (> = 40) | 141 | 18.2% |
Cardiovascular Disease § | ||
Any CVD | 206 | 26.2% |
Myocardial Infarction | 127 | 16.2% |
Stroke | 68 | 8.7% |
Peripheral Vascular Disease | 61 | 7.8% |
Number of prescription medications, mean (SD) | 785 | 6.2 (3.5) |
Number of MD visits in previous year, mean (SD) | 785 | 1.5 (2.2) |
Years since diagnosis of DM, mean (SD) | 785 | 9.9 (10.1) |
Antiplatelet therapy (aspirin or other) | 421 | 53.6% |
Aspirin only | 371 | 47.3% |
Non-aspirin platelet aggregation inhibitor only | 20 | 2.5% |
Aspirin and platelet aggregation inhibitor | 30 | 3.8% |
Antiplatelet therapy if known CVD | 206 | 78.2% |